Dr John Parker Joins PeriGen as Chief Medical Officer, Bringing Expertise to Advance Maternal and Infant Healthcare

PeriGen Inc, the market leader in FDA-cleared AI-based maternal-fetal early warning systems today announced the addition of John Parker, M.D., as the company’s new Chief Medical Officer.

Dr John Parker will work closely with PeriGen’s client base to optimize use of the company’s analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.

Dr. Parker joins PeriGen from OhioHealth, where he served in leadership roles in perinatal quality and as associate program director of the residency program at Riverside Methodist Hospital, the busiest labor and delivery hospital in the state of Ohio. He has 16 years of experience in obstetrics and gynecology.

Parker started his career in software development, serving as a developer, designer, sales support engineer, and consultant before deciding to pursue medicine. “John is a bit of a unicorn given his knowledge of systems design and development and practical experience as a physician leader and educator,” said Matthew Sappern, PeriGen CEO. “He is exceptional at helping PeriGen clients understand how to best leverage PeriGen analytics within their workflow.”

Other Executives In the News

SourcePeriGen
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy